Lung Cancer
Objectives
- Epidemiology and diagnosis of lung cancer
- Basic molecular biology of lung cancer
Projects in Progress
- Utility of integrated PET-CT in lung cancer
- Determination of miRNA in lung-cancer bronchial biopsies
- Utility of the use of biomarkers in lung cancer
Milestones Achieved
- Utility of USE-PAAF in diagnosing mediastinal lymph nodes
- Comparison of miRNA of human embryos and lung cancer
- Epidemiology of respiratory infection in lung cancer
Future Challenges
- Determination of miRNA in peripheral blood
- Use of miRNA levels as biomarkers of disease progression
- Use of miRNA levels as a potential therapeutic goal
Publications
microRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis
Navarro A, Marrades RM, Viñolas N, Quera A, Agustí C, Huerta A, Ramirez J, Torres A, Monzo M
Oncology 2008 (en premsa)
Punción transbronquial aspirativa en el estudio de las adenopatías mediastínicas: rentabilidad y coste-beneficio
Martinez-Olondris P, Molina M, Xaubet A, Marrades RM, Luburich P, Ramirez J, Torres A, Agusti C
Arch de Bronconeumol 2008;44:290-4
Transesophageal Ultrason-guided fine needle aspiration improves mediastinal staging in patients with Non Small-Cell Lung Cancer and normal mediastinum on computed tomography
Fernández-Esparrach G, Ginès A, Belda J, Pellisé M, Solé M, Marrades R, Sendino O, Colomo L, Mata A, Llach J, Bordas JM, Castells A
Lung Cancer. 2006 Oct;54(1):35-40
Lines list
- Animal Model
- Bronchiectasis non associated to Cystic Fibrosis (BQ-noFQ), Cystic Fibrosis (CF) and immune deficiencies
- Community-Acquired Pneumonia (CAP)
- Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
- Networks, European Projects and Collaborations
- Noninvasive Ventilation (NIV)
- Pulmonary complications in immunocompromised (IC) patients
- Translational research laboratory for advanced microbiology diagnosis and pathogen-host response in respiratory infections
- Ventilator-Associated Pneumonia (VAP)
